Rasagiline (Ascend Laboratories, LLC)


Welcome to the PulseAid listing for the Rasagiline drug offered from Ascend Laboratories, LLC. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ascend Laboratories, LLC
NON-PROPRIETARY NAME: Rasagiline
SUBSTANCE NAME: RASAGILINE MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-10-30
END MARKETING DATE: 0000-00-00


Rasagiline HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRasagiline from Ascend Laboratories, LLC
LABELER NAME: Ascend Laboratories, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2017-10-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67877-259_f21a6e0e-6778-4871-9d11-756a969f0e24
PRODUCT NDC: 67877-259
APPLICATION NUMBER: ANDA201889

Other RASAGILINE MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Rasagiline Mesylate
Aphena Pharma Solutions – Tennessee, LLCAzilect
Ascend Laboratories, LLCRasagiline
Mylan Pharmaceuticals Inc.Rasagiline Mesylate
Physicians Total Care, Inc.Azilect
Teva Neuroscience, Inc.Azilect
Teva Pharmaceuticals USA, Inc.Rasagiline